Episode 14: New directions in cancer diagnostics, with Janette Phi, Chief Business Officer of ThinkCyte

Janette Phi’s journey into healthcare technology is a personal one, driven by a medical issue her son experienced in his youth. Driven by her own story, she asks how medical normalisation and precision healthcare work together to bring the correct care to correct patient - with the potential to save lives. Join me, Dr Felix Beacher, and in Episode 14 of our podcast, we welcome Janette Phi, the Chief Business Officer of ThinkCyte. Janette shares her insights on how to grow a company and the challenges she has faced in leading ThinkCyte to success. We dive deep into the world of single-cell treatment, looking at how understanding one cell can help build medical frameworks of the whole body. We ask how doctors weigh the relationship between personal and general treatment, the growing field of precision medicine, and the importance of improving information sharing within the medical community. Join us as we explore new frontiers in using artificial intelligence to fight against cancer and bring well-needed healthcare to those who need it. Who is Today's Guest? Janette Phi is Chief Business Officer at ThinkCyte and is responsible for leading global business development and commercial activities. Phi brings over 30 years of technical and business experience with advanced scientific technology companies. She has served as CBO for IntelliCyt (acquired by Sartorius), COO for Xcell Biosciences and CCO for Applied Cells and ONI. She holds a B.S. in Cell Biology from the University of California, Berkeley and an MBA with an emphasis in Marketing & Finance from Santa Clara University Original music by Felix Beacher: https://youtu.be/JS93808r-W4